{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:34:23Z","timestamp":1781512463900,"version":"3.54.1"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Vestre Viken Hospital Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1111\/ane.13042","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T09:57:36Z","timestamp":1540979856000},"page":"192-198","source":"Crossref","is-referenced-by-count":15,"title":["Antiepileptic drug withdrawal in juvenile myoclonic epilepsy"],"prefix":"10.1155","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2182-4247","authenticated-orcid":false,"given":"Marte","family":"Syvertsen","sequence":"first","affiliation":[{"name":"Department of Neurology; Drammen Hospital, Vestre Viken Hospital Trust; Drammen Norway"},{"name":"Institute of Clinical Medicine; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Fl\u00f8gstad","sequence":"additional","affiliation":[{"name":"Programme for Pharmacy, Faculty of Health Sciences; Oslo Metropolitan University; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Enger","sequence":"additional","affiliation":[{"name":"Department of Neurology; Drammen Hospital, Vestre Viken Hospital Trust; Drammen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie Johannessen","family":"Landmark","sequence":"additional","affiliation":[{"name":"Programme for Pharmacy, Faculty of Health Sciences; Oslo Metropolitan University; Oslo Norway"},{"name":"The National Center for Epilepsy; Oslo University Hospital; Oslo Norway"},{"name":"Department of Pharmacology, Section for Clinical Pharmacology, The National Center for Epilepsy; Oslo University Hospital; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Koht","sequence":"additional","affiliation":[{"name":"Department of Neurology; Drammen Hospital, Vestre Viken Hospital Trust; Drammen Norway"},{"name":"Institute of Clinical Medicine; University of Oslo; Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"issue":"1","key":"10.1111\/ane.13042-BIB0001|ane13042-cit-0001","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/epi.13613","article-title":"Prevalence of juvenile myoclonic epilepsy in people <30 years of age-A population-based study in Norway","volume":"58","author":"Syvertsen","year":"2017","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1111\/ane.13042-BIB0002|ane13042-cit-0002","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.yebeh.2012.11.051","article-title":"Consensus on diagnosis and management of JME: from founder's observations to current trends","volume":"28","author":"Kasteleijn-Nolst Trenite","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"Suppl 1","key":"10.1111\/ane.13042-BIB0003|ane13042-cit-0003","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.yebeh.2013.01.001","article-title":"Management of juvenile myoclonic epilepsy","volume":"28","author":"Crespel","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1111\/ane.13042-BIB0004|ane13042-cit-0004","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1528-1157.1984.tb04163.x","article-title":"Some clinical and EEG aspects of benign juvenile myoclonic epilepsy","volume":"25","author":"Asconape","year":"1984","journal-title":"Epilepsia"},{"issue":"2","key":"10.1111\/ane.13042-BIB0005|ane13042-cit-0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1528-1157.1994.tb02432.x","article-title":"Juvenile myoclonic epilepsy: a 5-year prospective study","volume":"35","author":"Panayiotopoulos","year":"1994","journal-title":"Epilepsia"},{"issue":"3","key":"10.1111\/ane.13042-BIB0006|ane13042-cit-0006","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.34.3.285","article-title":"Juvenile myoclonic epilepsy of Janz","volume":"34","author":"Delgado-Escueta","year":"1984","journal-title":"Neurology"},{"issue":"10","key":"10.1111\/ane.13042-BIB0007|ane13042-cit-0007","first-page":"525","article-title":"R\u00fcckfallprognose nach Reduktion der Medikamente bei Epilepsiebehandlung [Relapse prognosis following reduction of drugs in epilepsy treatment]","volume":"54","author":"Janz","year":"1983","journal-title":"Nervenarzt"},{"issue":"7","key":"10.1111\/ane.13042-BIB0008|ane13042-cit-0008","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.seizure.2011.03.007","article-title":"Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy","volume":"20","author":"Pavlovic","year":"2011","journal-title":"Seizure"},{"key":"10.1111\/ane.13042-BIB0009|ane13042-cit-0009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.seizure.2018.05.015","article-title":"Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy","volume":"59","author":"Healy","year":"2018","journal-title":"Seizure"},{"issue":"3","key":"10.1111\/ane.13042-BIB0010|ane13042-cit-0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1528-1167.2007.01323.x","article-title":"Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study)","volume":"49","author":"Lossius","year":"2008","journal-title":"Epilepsia"},{"issue":"6","key":"10.1111\/ane.13042-BIB0011|ane13042-cit-0011","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jocn.2012.07.010","article-title":"Predictors for relapse after antiepileptic drug withdrawal in seizure-free patients with epilepsy","volume":"20","author":"Su","year":"2013","journal-title":"J Clin Neurosci"},{"issue":"10","key":"10.1111\/ane.13042-BIB0012|ane13042-cit-0012","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.addr.2011.10.003","article-title":"Host factors affecting antiepileptic drug delivery-pharmacokinetic variability","volume":"64","author":"Johannessen Landmark","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1111\/ane.13042-BIB0013|ane13042-cit-0013","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1684\/epd.2016.0880","article-title":"Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring","volume":"18","author":"Landmark","year":"2016","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1111\/ane.13042-BIB0014|ane13042-cit-0014","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.seizure.2005.04.007","article-title":"Self-perception of factors that precipitate or inhibit seizures in juvenile myoclonic epilepsy","volume":"14","author":"Silva","year":"2005","journal-title":"Seizure"},{"issue":"22 Pt 2","key":"10.1111\/ane.13042-BIB0015|ane13042-cit-0015","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1212\/01.wnl.0000313148.34629.1d","article-title":"Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy","volume":"70","author":"Baykan","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"10.1111\/ane.13042-BIB0016|ane13042-cit-0016","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1528-1167.2012.03526.x","article-title":"Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up","volume":"53","author":"Geithner","year":"2012","journal-title":"Epilepsia"},{"issue":"24","key":"10.1111\/ane.13042-BIB0017|ane13042-cit-0017","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/01.wnl.0000437303.36064.f8","article-title":"Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors","volume":"81","author":"Senf","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1111\/ane.13042-BIB0018|ane13042-cit-0018","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2014.01.012","article-title":"Clinical heterogeneity of juvenile myoclonic epilepsy: follow-up after an interval of more than 20 years","volume":"23","author":"Syvertsen","year":"2014","journal-title":"Seizure"},{"issue":"10","key":"10.1111\/ane.13042-BIB0019|ane13042-cit-0019","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.eplepsyres.2014.09.008","article-title":"Seizure outcome in 175 patients with juvenile myoclonic epilepsy-a long-term observational study","volume":"108","author":"Hofler","year":"2014","journal-title":"Epilepsy Res"},{"issue":"11-12","key":"10.1111\/ane.13042-BIB0020|ane13042-cit-0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2298\/MPNS1412372J","article-title":"Terminal remission is possible in some patients with juvenile myoclonic epilepsy without therapy","volume":"67","author":"Jovic","year":"2014","journal-title":"Med Pregl"},{"issue":"13","key":"10.1111\/ane.13042-BIB0021|ane13042-cit-0021","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181b9c86f","article-title":"Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study","volume":"73","author":"Camfield","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1111\/ane.13042-BIB0022|ane13042-cit-0022","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/epi.12003","article-title":"Frontal lobe function and structure in juvenile myoclonic epilepsy: a comprehensive review of neuropsychological and imaging data","volume":"53","author":"Wandschneider","year":"2012","journal-title":"Epilepsia"},{"issue":"12","key":"10.1111\/ane.13042-BIB0023|ane13042-cit-0023","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/epi.12413","article-title":"Risk-taking behavior in juvenile myoclonic epilepsy","volume":"54","author":"Wandschneider","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1111\/ane.13042-BIB0024|ane13042-cit-0024","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00415-012-6715-z","article-title":"Decision making in juvenile myoclonic epilepsy","volume":"260","author":"Zamarian","year":"2012","journal-title":"J Neurol"},{"issue":"5","key":"10.1111\/ane.13042-BIB0025|ane13042-cit-0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/epi.12972","article-title":"Prevalence and etiology of epilepsy in a Norwegian county-A population based study","volume":"56","author":"Syvertsen","year":"2015","journal-title":"Epilepsia"},{"key":"10.1111\/ane.13042-BIB0026|ane13042-cit-0026","unstructured":"Statistics Norway Key figures for the population https:\/\/www.ssb.no\/en\/befolkning\/nokkeltall\/population"},{"issue":"1","key":"10.1111\/ane.13042-BIB0027|ane13042-cit-0027","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results","volume":"42","author":"Herrmann","year":"1997","journal-title":"J Psychosom Res"},{"key":"10.1111\/ane.13042-BIB0028|ane13042-cit-0028","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J Clin Psychol"},{"issue":"4","key":"10.1111\/ane.13042-BIB0029|ane13042-cit-0029","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"8","key":"10.1111\/ane.13042-BIB0030|ane13042-cit-0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/epi.13061","article-title":"Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: an extended study","volume":"56","author":"Iqbal","year":"2015","journal-title":"Epilepsia"},{"issue":"6","key":"10.1111\/ane.13042-BIB0031|ane13042-cit-0031","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.wco.0000194141.56429.3c","article-title":"Decision-making and impulse control after frontal lobe injuries","volume":"18","author":"Bechara","year":"2005","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1111\/ane.13042-BIB0032|ane13042-cit-0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ane.12578","article-title":"Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs","volume":"135","author":"Mevaag","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.13042-BIB0033|ane13042-cit-0033","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2014.05.011","article-title":"The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy","volume":"36","author":"Ettinger","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1111\/ane.13042-BIB0034|ane13042-cit-0034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","article-title":"Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial","volume":"62","author":"Gilliam","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/ane.13042-BIB0035|ane13042-cit-0035","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13811","article-title":"Refractory juvenile myoclonic epilepsy: A meta-analysis of prevalence and risk factors","author":"Stevelink","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1111\/ane.13042-BIB0036|ane13042-cit-0036","unstructured":"World Health Organization Adherence to long-term therapies - evidence for action https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42682\/9241545992.pdf"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.13042","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.13042\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:47:00Z","timestamp":1671540420000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.13042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.13042","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}